Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
AA, absorption, acute, adsorption, Amersfoort, ancillary, answer, Anza, Arabia, assumption, await, backup, Branch, budget, catastrophic, Caufield, classification, collateral, compromised, computerized, conductingin, consumption, core, corruption, curtailed, damage, defective, derecognition, deyhydration, director, distributor, driven, du, EFS, entitled, Etablissement, expend, facilitate, Fenwal, Freight, Gail, Greece, headquartered, herewith, incidence, intangible, irreversible, Italy, Kleiner, knowledge, Kuwait, lifespan, Listaria, lose, MacoPharma, magnitude, maker, Malaysia, media, Ministry, mix, mortgage, ofin, operationally, outage, outdated, passed, Poland, Portugal, post, predominantly, purpose, reclassified, recourse, recreate, regularly, representation, resale, round, Russia, Sang, Saudi, Schulze, sensitive, sequelae, shareholder, ship, Shipping, Sofinnova, sooner, Spain, statutory, sublease, subleased, successor, SwissMedic, syndicate, tangible, tender, thereof, travel, Turkey, turnover, ultimately, unachievable, unblinding, undelivered, unfulfilled, unrecognized, upcoming, Versant, vitroand, vitroandin, warranty, workmanship
Removed:
Academy, achievement, allegedly, alleging, anthrax, antigen, attack, bacterium, biodefense, biologic, BLA, breast, Brewery, capable, Chugai, clause, closing, collaborating, colon, colorectal, combined, comparison, complaint, computing, counterparty, Dendreon, derive, description, dispute, DNA, duty, elicit, employing, engineered, entity, experimental, false, feasibility, fiduciary, Finally, formation, forward, fourth, Helinx, immune, impair, inappropriate, IND, infectivity, inhibit, intensely, invention, killed, Kirin, live, liver, Maco, melanoma, Mesothelin, metabolic, metastasized, metastatic, mice, misleading, moving, optimized, outcome, ovarian, pancreatic, Pharma, pivotal, plaintiff, potency, potent, prevalently, proceeding, profile, prolonged, promising, prostate, protein, purported, RAC, realigned, realignment, recognizing, Recombinant, reportable, request, response, selectively, sequence, sharing, solid, Squibb, stability, stem, strain, survival, switch, tested, toxicity, training, transplantation, tumor, University, unmet, unspecified, utilizing, vaccinated, versatile, view, violated, volumetric, workforce
Filing tables
Filing exhibits
- 10-K Annual report
- 10.28 Asset Transfer and License Agreement, Dated November 20, 2007
- 10.29 Offer Letter to Gail Schulze, Dated October 15, 2007
- 10.30 Base Salaries for Fiscal Year 2007 for Named Executive Officers
- 21.1 List of Registrant's Subsidiaries
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of the Chief Executive Officer of Cerus Pursuant to Section 302
- 31.2 Certification of the Chief Financial Officer of Cerus Pursuant to Section 302
- 32.1 Certification of the Chief Executive Officer and Chief Financial Officer
Related press release
CERS similar filings
Filing view
External links